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LETTER TO EDITOR
Microbiome analysis reveals that Ralstonia is responsible for
decreased renal function in patients with ulcerative colitis
Dear Editor,
The causal link between inflammatory bowel disease
(IBD) and chronic kidney disease (CKD) is not clear; there-
fore, we aimed to investigate the role of gut microbiota
in decreasing renal function in patients with IBD. IBD is
characterized by the disruption of host–microbe relation-
ships, and dysbiosis and the metabolites produced by the
dysbiotic intestinal microbiome may negatively influence
the renal function.1 Indeed, epidemiological studies have
shown that the prevalence of CKD is higher in individu-
als with ulcerative colitis (UC) compared to those without
UC.2,3
To reveal the connection between UC and CKD, we
performed 16S ribosomal DNA sequencing using ileoce-
cal mucosal samples from nine patients with both UC and
CKD, 29 UC patients with normal renal function, and 12
healthy individuals who had normal colonoscopy results
(Table S1; Figure S1). The patients with CKD showed esti-
mated glomerular filtration rate (eGFR) values less than
60 mL/min/1.73 m2 for a minimum of 3 months.
The bacterial operational taxonomic units of patients in
the UC + CKD group were decreased but were not signifi-
cantly different from those of the UC or control group (Fig-
ure S2A>). Community richness, such as the Chao1 index
and abundance-based coverage estimator (ACE), was not
different among the three groups (Figure S2B andC).How-
ever, the Shannon diversity index and the inverse Simp-
son diversity index were significantly decreased in the
UC+CKD group compared to that in the control or UC
group (Figure S2D and E), suggesting that the bacterial
diversity was lower in the UC + CKD group. Additionally,
eGFRwas significantly positively correlatedwith the Shan-
non index and the inverse Simpson index (Table S2). The
principal component analysis showed an overlap to some
extent among the three groups, indicating similar bacterial
community structures (Figure S2F).
Among six bacterial phyla which accounted for over 97%
of taxonomy in the gut microbiota of the study population,
Actinobacteria exhibited the highest relative abundance in
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the UC + CKD group (Figure 1A). In addition, Fusobacte-
ria was detected in some individuals with UC (Figure 1B).
At the genus and species level, 24 genera and 23 species
showed a relative abundance of more than 1% (Figure 1C
and D).
Of the 10 genera that were relatively abundant in the
study population, only Ralstonia showed a higher relative
abundance in the UC + CKD and UC groups compared to
that in the control group (Figure 1E). Furthermore, Ralsto-
nia_uc (unclassified Ralstonia species) showed the highest
relative abundance in the UC + CKD group (Figure 1F).
Additional real-time PCR on colon biopsy samples of UC
+ CKD and UC patients using primers specific for Ralsto-
nia pickettii indeed validated the presence of the microbe
only in the UC + CKD group (Figure 1G).
When the correlation of relative abundance of microbes
with eGFR in the UC+ CKD group was examined, the rel-
ative abundance of seven genera including Ralstonia and
four species includingRalstonia_uc showed a negative cor-
relation with eGFR (Figure 2A; Figure S3A; Table S3). Fur-
thermore, the relative abundances of Ralstonia and Ralsto-
nia_uc showed a positive correlation with the serum uric
acid level (Figure 2B; Figure S3B), whereas relative abun-
dances of Anaerostipes hadrus and Citrobacter portucalen-
sis did not correlate with eGFR and serum uric acid level
(Figure S3C–F).
Among several species of the Ralstonia genus, we
selected R. pickettii because it is a keymember of the genus
and implicated in human pathogenicity.4 Among various
inflammatory markers associated with the UC patients,
three pro-inflammatory cytokine genes were chosen to
examine the effect of R. pickettii treatment on Caco-2 cells.
The treatment of Caco-2 cells with R. pickettii induced the
upregulation of mRNA levels of these pro-inflammatory
cytokines (IL1β, IL6, and TNF-α) by at least twofold com-
pared to that of the untreated control samples (Figure 3A).
This suggests that R. pickettii contributed to the inflamma-
tion seen in an UC in vitro assay resembling the intestinal
conditions of UC patients.
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F IGURE 1 The taxonomic composition of the gut microbiota of the study population and comparison of the 10 most abundant genera
and species in the UC + CKD, UC, and control groups. (A, B) The taxonomic composition of each group (A) and individual samples (B) at
the phylum level. (C) The genera with greater than 1% relative abundance. (D) The species with greater than 1% relative abundance. (E) At the
genus level, the abundance of Ralstonia was significantly higher in the UC + CKD and UC groups than that in the control group. (F) At the
species level, the abundances of Ralstonia_uc andCitrobacter portucalensiswere significantly higher in the UC+CKD group compared to those
in the other groups, whereas the abundance of Anaerostipes hadruswas significantly higher in the control group compared to that in the other
groups. (G) Real-time PCR on all available RNA samples extracted from colon biopsy samples in the UC + CKD and UC groups validated the
higher abundance of Ralstonia pickettii in the UC+ CKD group than that of the UC group with statistical significance. *p < 0.05; CKD, chronic
kidney disease; UC, ulcerative colitis
F IGURE 2 The correlation between the
relative abundance of Ralstonia with renal
function (indicated by eGFR) and serum uric
acid level. (A, B) The relative abundance of
Ralstonia_uc was negatively correlated with
eGFR (CKD-EPI) (A) and positively
correlated with the serum uric acid level (B).
Results of the UC + CKD group patients (red
dots) and the UC group patients (green dots)
were collectively analyzed
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F IGURE 3 Effects of Ralstonia pickettii on Caco-2 cells and kidney organoids. (A) mRNA expression of pro-inflammatory cytokine genes
in Caco-2 cells treated with and without Ralstonia pickettii, reflecting the inflammation seen in ulcerative colitis. (B) Schematic diagram of the
co-culture experiment. (C) Immunofluorescence staining of LTL,KIM-1, andE-cadherin in kidney organoids treatedwith andwithoutRalstonia
pickettii. (D, E) Expression of acute injury (D) and renal marker (E) genes in the control and Ralstonia pickettii treated kidney organoids
To model the gut–kidney axis, we utilized a co-culture
of Caco-2 cells and kidney organoids in a transwell sys-
tem; the kidney organoids were not directly exposed
to R. pickettii (Figure 3B). Kidney organoids were gen-
erated from human-induced pluripotent stem cells as
described previously.5 Ralstonia-treated kidney organoids
presented markedly increased expression of KIM-1 com-
pared to the untreated control samples (Figure 3C). On
the contrary, mildly decreased expression of proximal
tubule marker, lotus tetragonolobus lectin (LTL), and dis-
tal tubule marker, E-cadherin, was observed in R. pickettii
treated kidney organoids compared to the untreated con-
trol samples, indicating damage within the kidney tubules
(Figure 3C). Furthermore, transcriptional activation of
KIM-1 and CYR61 in the R. pickettii treated organoids was
statistically significant (Figure 3D), and the expression of
the renal markers ECAD, PAX8, and CALB was signifi-
cantly decreased to 0.26-, 0.23-, and 0.38-fold, respectively
(Figure 3E). It is interesting that not only the acute kid-
ney injury markers but also the structural markers were
affected by Ralstonia treatment, indicating that virulence
factors such as endotoxins can provoke renal dysfunction
through the gut–kidney axis.
In this study, we found that the abundance of Ralstonia
was significantly higher in theUC+CKDgroup at both the
genus and species levels. The relative abundance of Ral-
stonia was positively correlated with serum uric acid level
and negatively correlated with eGFR. Ralstonia is an aer-
obic, gram-negative, nonfermentable rod, and an oppor-
tunistic pathogen that causes infections in immunocom-
promised hosts. Intestinal R. pickettii is associated with
the significant increase in endotoxin levels and worsened
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glucose intolerance in obesity.6 An increase in plasma
endotoxin levels eventually results in systemic endotox-
emia and chronic inflammation.7 Endotoxemia is a char-
acteristic of CKD and is associated with the CKD stage and
decreased survival.8
The limitations of this study include its cross-sectional
nature, relatively small number of patients, and rela-
tively high variability in the microbial composition of each
group. Additional studies with larger sample sizes might
be necessary to confirm the findings of the present study.
In addition, the results of this study will be strengthened
by comparing the current data with those for the micro-
biome of patients with Crohn’s disease and CKD, and CKD
patients without IBD. Further studies are required regard-
ing potential confounding factors such as contamination in
the 16S rRNA microbiome studies.9 In vitro studies utiliz-
ing clinical isolates ofR. pickettii from fecal culture samples
might also validate our findings.
In conclusion, the present study demonstrates a change
in the microbial community in patients with UC and
decreased renal function. R. pickettii was negatively corre-
lated with renal function in individuals with UC and asso-
ciated with kidney-specific disruptive features especially
under the inflamed colon, suggesting thatR. pickettiimight
play an important role in the pathogenesis of CKD in UC.
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